Skip to main content
. 2008 Jul 1;99(1):126–132. doi: 10.1038/sj.bjc.6604458

Table 1. Levels of DCD expression in primary tissue and cell lines for each organ site.

        Dermcidin expression level
  Number of samples
  Number of samples
Organ Benign Cancer Cell line Sample type: benign, cancer or cell line Very high (%) High (%) Moderate (%) Low/absent (%) Not detected/below the limits of detection (%)
Oesophagus 5a 28 0 Benign: 0 0 0 0 5 (100)
        Cancer: 0 0 0 4 (14.3) 24 (85.7)
Stomach 5a 20 0 Benign: 0 0 0 0 5 (100)
        Cancer: 0 0 2 (10) 3 (15) 15 (75)
Pancreas 2b 5 2 Benign: 0 0 0 0 2 (100)
        Cancer: 0 2 (40) 1 (20) 0 2 (40)
        Cell Line: 0 0 1 (50) 1 (50) 0
Bile duct 0 1 0 Cancer: 0 1 (100) 0 0 0
Prostate 16c 52 4 Benign: 0 0 0 0 16 (100)
        Cancer: 0 0 0 0 52 (100)
        Cell Line: 0 0 0 3 (75) 1 (25)
Others 2d 1e 0 Benign: 0 0 0 0 2 (100)
        Cancer: 0 0 0 1 (100) 0
a

Benign samples taken during normal upper gastrointestinal endoscopy examinations.

b

Chronic pancreatitis samples.

c

Benign prostatic hypertrophy samples.

d

Pancreatic liposarcoma and adenoma.

e

Pancreatic cystadenoma.